Home › NDC Lookup › Ingredients › Silver Nitrate › 68599-6303-08
Swabs Silver Nitrate 25 g/100mL; 75 g/100mL Swab, 10-count — NDC 68599-6303-08 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Swabs Silver Nitrate 25 g/100mL; 75 g/100mL Swab, 10-count — NDC 68599-6303-8 (Billing 68599-6303-08)

by McKesson · 10 SWAB in 1 BOX

This is a package of 10 swabs of Swabs Silver Nitrate 25 g/100mL; 75 g/100mL Swab from McKesson, marketed since Apr 2020 and currently FDA-listed. It is this product's only package size.

NDC 68599-6303-08
🏷️ FDA NDC (as labeled) 68599-6303-8 billing pads the package segment with a zero
Rx only On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 68599-6303-8 alone.

Record
FDA NDC Directory package listing · Human prescription drug
Code segments
68599 labeler · 6303 product · 8 package
Package marketed since
Apr 21, 2020
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Billing quantity
10 EA per package
Barcode (UPC)
0368599630382
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 68599-6303-8
Product NDC 68599-6303
11-digit billing NDC 68599630308
NCPDP billing unit EA — each (per item)
RxCUI 1117536
UNII RU45X2JN0Z, 95IT3W8JZE
UPC 0368599630382
SPL Set ID a3ce4ed7-983f-55ef-e053-2a95a90a5efa
DEA schedule Non-controlled
Marketing category UNAPPROVED DRUG OTHER
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2020-04-21
Route TOPICAL
Dosage form SWAB
Substance POTASSIUM NITRATE; SILVER NITRATE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GCN Seq No 062055
GCN 97839
HICL code 017855
Ingredient (HICL) Silver Nitrate Applicator
HIC1 code L
Therapeutic class — broad (HIC1) Skin/Subcutaneous Tissue
HIC2 code L5
Therapeutic class — intermediate (HIC2) Keratolytics/Keratoplastics
HIC3 code L5A
Therapeutic class — specific (HIC3) Keratolytics
AHFS code 84:28.00.00
AHFS class Keratolytic Agents
FDB label name SILVER NITRATE APPLICATOR 6"
FDB brand name Silver Nitrate Applicator
Legend status F — Federal legend — prescription drug or device
Quick answers
  • GSN (GCN sequence number): 062055
  • GCN: 97839
  • HICL (First Databank): 017855
  • AHFS class code: 84:28.00.00
  • RxCUI (RxNorm): 1117536
Why two NDCs? The FDA registers this code as 68599-6303-8 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 68599-6303-08. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

Label name SILVER NITRATE APPLICATOR 6" Ingredient Silver Nitrate Applicator
🧪 What is this product?

This is a topical swab product containing silver nitrate and potassium nitrate as active ingredients. Silver nitrate is commonly used in topical preparations for cauterization and removal of certain growths or lesions on skin and mucous membranes. Potassium nitrate appears in this formulation as well. This product is an unapproved drug and is not marketed under an FDA-approved application.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
68599-6303-08 You're viewing this Main listing 10 SWAB in 1 BOX 2020-04-21 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Styptstix 38.21 mg/1; 12.74 mg 00404-1000-01 Henry 12 tubes — — FDA listed —
Grafco Applicator 15 Cm 38.21 mg/1; 12.74 mg 12165-0100-01 GF 100 sticks — — FDA listed —
Grafco Applicator 30 Cm 52.451 mg/1; 17.486 mg 12165-0200-03 GF 100 sticks — — FDA listed —
Grafco Applicator 45 Cm 73.4314 mg/1; 24.4804 mg 12165-0300-01 GF 1 stick — — FDA listed —
Silver Nitrate Applicators 25 mg/100mg; 75 mg/100mg 12870-0001-01 Arzol 10 packets — — FDA listed —
Grafco Silver Nitrate (75% Silver Nitrate, 25% Potassium Nitrate) 12.74 mg/1; 38.21 mg 51662-1611-01 HF 100 sticks — — FDA listed —
Avoca Flexible Caustic Applicator 30 mg/40mg 65875-0101-09 Bray 10 vials — — FDA listed —
Swabs 25 g/100mL; 75 g/100mLthis 68599-6303-08 McKesson 10 swabs — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2020
On the market since
Apr 2020
📍
2026
Currently FDA-listed
6 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

A current SPL was checked, but it does not contain a structured or narrative inactive-ingredient list for this product. This does not mean the product has no inactive ingredients.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerMcKesson
Labeler code68599
First marketedApr 2020
Product typeHuman Prescription Drug
Portfolio27 products on file

More NDCs from McKesson labeler code 68599

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

Full prescribing information FDA SPL

The complete FDA label for this product — the official prescribing information, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⛔ Contraindications ⚠️ Warnings and Cautions 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 22 words ▾

USES: Caustic applicators are useful for cauterization of skin or mucous membrane and for the removal of granulation tissue, warts and verrucae.

⏱️ Dosage and Administration 82 words ▾

DOSAGE & ADMINISTRATION: Prior to use, the applicator stick may be bent or shaped to allow easier access to the target area. The medicated end of the applicator should be moistened in clean water and applied to the affected tissue. One applicator is normally sufficient for each application.

The strength of the action is controlled by the amount of water used to moisten the tip. The applicator action can be stopped by washing the area with a saline solution (0.9% sodium chloride).

⛔ Contraindications 99 words ▾

CONTRAINDICATIONS & ANTIDOTES: Caustic applicators must not be used for genital warts. Continued application to mucous membranes and open wounds leads to argyria, a bluish-black discoloration of the skin due to depositions of granules of silver compounds in the connective tissues. This condition persists indefinitely or disappears very slowly.

Poisoning by oral ingestion is unlikely with the quantities involved, but treatment for poisoning is the immediate ingestion of large amounts of salt water followed by an emetic. Then administer a dose of Epsom Salts followed with milk. Immediately call a physician.

CAUTION: Federal (USA) law prohibits dispensing without prescription.

⚠️ Warnings and Cautions 93 words ▾

CAUTION: Federal (USA) law prohibits dispensing without prescription. Keep out of reach of children. Do not use on or near eyes.

Do not use on genital warts. Avoid storage in direct sunlight/fluorescent lighting and store in a cool, dry, and well-ventilated area. Store at room temperature in the closed package, in a dry place protected from light.

Exposure to light will cause the silver nitrate tip to turn black, but will not affect the product's potency. Not made with natural rubber latex. Questions?

Call 1-800-777-4908 Distributed by McKesson Medical-Surgical Inc. Richmond, VA 23233

📄 Package Label / Principal Display Panel 102 words ▾

NDC 68599-6303-8 McKESSON Silver Nitrate Applicators SILVER NITRATE 75% | POTASSIUM NITRATE 25% 6 in FLEXIBLE CAUSTIC APPLICATOR 100 PER VIAL 10 VIALS PER BOX DO NOT REUSE Rx ONLY MFR # 63-4100 box

NDC 68599-6303-8 McKESSON Silver Nitrate Applicators SILVER NITRATE 75% | POTASSIUM NITRATE 25% 6 in FLEXIBLE CAUSTIC APPLICATOR 100 PER VIAL 10 VIALS PER BOX DO NOT REUSE Rx ONLY MFR # 63-4100 each

NDC 68599-6303-8 McKESSON Silver Nitrate Applicators SILVER NITRATE 75% | POTASSIUM NITRATE 25% 6 in FLEXIBLE CAUSTIC APPLICATOR 100 PER VIAL 10 VIALS PER BOX DO NOT REUSE Rx ONLY MFR # 63-4100 case

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Swabs (this brand).

Top reported reactions

Pemphigus1,529
Glossodynia1,527
Joint Swelling1,510
Hand Deformity1,508
Helicobacter Infection1,501
Infusion Related Reaction1,494
Impaired Healing1,490

Reporter sex

3,777 reports
Male · 5%
Female · 95%
Unknown · 0%

Serious outcomes

Disabling2,642
Hospitalization2,514
Death2,356
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 265 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Finished prescription product Marketed without an FDA application

Listed without an FDA application

This product's marketing category indicates it is marketed without an approved FDA application (no NDA, ANDA, or BLA on file). Having an NDC does not by itself establish FDA approval — the NDC Directory is a listing system, not an approval decision. Approval-linked data such as Orange Book therapeutic-equivalence ratings therefore does not apply.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Drug Other". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by McKesson. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
McKesson is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as a prescription product, so it is dispensed under a prescriber's order. Your pharmacist can tell you whether any over-the-counter forms of the same medication exist.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 68599-6203-04 · McKesson 68599-7100-01 · McKesson →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.